Greenwood Capital Associates’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-51,289
| Closed | -$1.97M | – | 244 |
|
|
2024
Q2 | $1.97M | Sell |
51,289
-1,911
| -4% | -$73.6K | 0.26% | 91 |
|
|
2024
Q1 | $2.28M | Sell |
53,200
-3,076
| -5% | -$132K | 0.3% | 82 |
|
|
2023
Q4 | $2.09M | Sell |
56,276
-742
| -1% | -$27.5K | 0.27% | 85 |
|
|
2023
Q3 | $2.07M | Buy |
57,018
+709
| +1% | +$25.7K | 0.3% | 84 |
|
|
2023
Q2 | $2.01M | Sell |
56,309
-378
| -0.7% | -$13.5K | 0.28% | 83 |
|
|
2023
Q1 | $2.02M | Buy |
56,687
+4,491
| +9% | +$160K | 0.29% | 86 |
|
|
2022
Q4 | $1.83M | Buy |
52,196
+720
| +1% | +$25.3K | 0.3% | 73 |
|
|
2022
Q3 | $1.52M | Buy |
51,476
+23,764
| +86% | +$699K | 0.26% | 84 |
|
|
2022
Q2 | $1.51M | Buy |
27,712
+2,122
| +8% | +$115K | 0.24% | 80 |
|
|
2022
Q1 | $1.39M | Buy |
25,590
+4,915
| +24% | +$268K | 0.37% | 48 |
|
|
2021
Q4 | $1.14M | Buy |
20,675
+2,893
| +16% | +$160K | 0.16% | 110 |
|
|
2021
Q3 | $849K | Buy |
17,782
+6,096
| +52% | +$291K | 0.13% | 128 |
|
|
2021
Q2 | $582K | Buy |
+11,686
| New | +$582K | 0.09% | 171 |
|